Washington, DC, August 22, 2011 The American Association for Clinical Chemistry (AACC) announces a series of free, online, on demand webinars designed for the global community of Spanish speaking laboratory professionals. The program is targeted at laboratory technologists, managers, administrators and directors; pathologists; public health professionals and those in related fields. The programs are available in English and Spanish: the Spanish language version made available by a generous grant from the Wallace H. Coulter Foundation.
The first program in the series, Advances in Tuberculosis Testing, is available from August. Supported by Cepheid, the webinar will address two topics: The Global Burden of Tuberculosis (TB) and Multi-drug resistant TB (MDR-TB). The World Health Organization estimates that 9 million people develop TB worldwide each year with a mortality rate exceeding 20 percent. In addition, nearly 10 percent of those diagnosed are HIV positive. Adding to the challenge, most of the cases occur in resource-limited countries where rapid diagnosis and treatment can be difficult, thereby accelerating the spread of the disease. MDR-TB is caused by TB bacilli resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs available. In 2008, the WHO estimated that there were 440,000 cases of MDR-TB with the largest number of estimated cases in China, India, Russia and South Africa. MDR-TB poses a serious threat to controlling the spread of disease.
The expert faculty for the webinar is Christopher Gilpin, PhD, MPH, from the World Health Organization in Geneva, Switzerland, and Matthew J. Bankowski, PhD, Vice President and Technical Director of Clinical & Molecular Microbiology and Infectious Disease, Diagnostic Laboratory Services and The Queen’s Medical Center, Honolulu, Hawaii.
The other webinars in the series are Reducing Pre-and Post-Analytical Errors, available September 2011 and featuring Mario Plebani, MD, Full Professor, Clinical Biochemistry and Clinical Molecular Biology, School of Medicine, University of Padova; Chief, Department of Laboratory Medicine, University-Hospital of Padova; Chief of the Center of Biomedical Research, Padova, Italy; and Cardiac Markers for Patients with Acute Coronary Syndromes and Heart Failure, available October 2011, featuring Alan H.B. Wu, PhD, Chief of Clinical Chemistry and Toxicology at San Francisco General Hospital and Professor of Laboratory Medicine, University of California, San Francisco, CA, USA. Both webinars are supported by Ortho-Clinical Diagnostics.
For more information about this important program or AACC, contact Peter Patterson by email or on either of the above phone numbers.